In Scientific American
From my article in a special issue of Scientific American sponsored by the Davos Alzheimer’s Collaborative, published April 15, 2024
The drug treatments that attack plaque are going to become increasingly effective, insist most researchers. Now that two anti-plaque drugs have been proven to slow the progress of cognitive decline, researchers and pharmaceutical companies can focus on new, better ways of hitting plaque….Whether through existing anti-plaque drugs or new ones, researchers expect to see more patients get more benefits as research and clinical experience help find ways to match the right drug to the right patients, and to zero in on the optimal doses and timing….Read more
David H. Freedman 